Table 1 Characteristics of individuals in the primary cohort
Characteristic | Chronic HCV (n = 64) | Resolved HCV (n = 73) | |
|---|---|---|---|
HIVneg (n = 45) | HIVpos (n = 28) | ||
Age (years)a | 50 (47–59) | 59 (49–67) | 54 (47–64) |
BMIa | 23.5 (21.1–26.1) | 23.2 (21.3–26.3) | 22.1 (20.5–24.5) |
Anti-HCV | Positive | Positive | Positive |
Anti-HIV | Negative | Negative | Positive |
HCV RNA (log10 IU/mL)a | 6.17 (5.82–6.54) | Negative | Negative |
HCV genotype | |||
1b (n,%)b | 39 (60.9%) | – | – |
2a (n,%)b | 25 (39.1%) | – | – |
Others | None | – | – |
ALT (n,%) | |||
> 40 (IU/L)b | 28 (43.7%) | 4 (8.9%) | 7 (25.0%) |
≤40 (IU/L)b | 36 (56.3%) | 41 (91.1%) | 21 (75.0%) |
AST (n,%) | |||
> 40 (IU/L)b | 30 (46.9%) | 1 (2.2%) | 7 (25.0%) |
≤40 (IU/L)b | 34 (53.1%) | 44 (97.8%) | 21 (75.0%) |
CD4+ T cells/μLa | 882 (599–1088) | 888 (658–1119) | 445 (346–587) |